3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Triple Negative Breast Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neoplasms
1
Myelodysplastic Syndromes
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Prolymphocytic, B-Cell
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Biphenotypic, Acute
1
Kidney Neoplasms
1
Glioma
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Burkitt Lymphoma
1
Interventions
durvalumab
7
Gemcitabine
7
Oxaliplatin
6
Magnetic Resonance Spectroscopy
6
Leucovorin
6
Cisplatin
6
Specimen Handling
5
Fluorouracil
5
Biopsy
5
Paclitaxel
4
Folfox protocol
4
Irinotecan
3
pemigatinib
2
pembrolizumab
2
olaparib
2
futibatinib
2
fludarabine
2
dehydroftorafur
2
Taxes
2
Nivolumab
2
Immunoglobulin G
2
Fluorodeoxyglucose F18
2
Disulfides
2
Carboplatin
2
zimberelimab
1
zanidatamab
1
ulixertinib
1
tremelimumab
1
trametinib
1
tocilizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cholangiocarcinoma
×
Blood Component Removal
×
30 days
×
Clear all
No trials found.